• Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JME, Epstein J. Br J Clin Pharmacol 2017 Dec 20. [Epub ahead pf print].

  • Oral iron treatment response and predictors in anaemic adolescents and adults with IBD. Rampton DS, Goodhand JR, Joshi NM, Karim AB, Koodun Y, Barakat FM, Macken L, Ward DG, Iqbal TH, Epstein J, Fell JM, Sanderson IR J Crohns Colitis. 2017 Jun 1;11(6):706.

  • Assessing the colonic microbiota in children: Effects of sample site and bowel preparation. Shaw AG, Black N, Rushd A, Sim K, Randell P, Kroll JS, Epstein J. J Pediatr Gastroenterol Nutr. 2017 Feb; 64(2):230-237.

  • Local chemokine profiling in eosinophilic esophagitis: The synthetic absorptive matrix test. Minshall E, Patel H, Francis N, Hansel TT, Warner JO, Boyle RJ, Fell J, Epstein J. Pediatr Allergy Immunol. 2017 Feb; 28(1):100-102.

  • Chronic recurrent multifocal osteomyelitis and inflammatory bowel disease: UK case series and literature review. Audu G, Nikaki K, Crespi D, Spray C, Epstein J. J Pediatr Gastroenterol Nutr 2015 May; 60(5):586-591.

  • Recent advances in the pathophysiology and management of eosinophilic oesophagitis. Epstein J, Warner JO. Clin Exp Allergy. 2014 Jun;44(6):802-12.

  • Do children with IBD really respond better than adults to thiopurines? Goodhand J, Rao A, Kotta S, Wahed M, Croft N, Sanderson I, Epstein J, Rampton D. J. Paediatr Gastroenterol Nutr 2011 Jun; 52(6); 702-7.

  • Curcumin as a therapeutic agent: The evidence from in vitro, animal and human    studies. Epstein J, Sanderson I, MacDonald T. Br J Nutr. 2010 Jun; 103(11):1545-57.

  • Curcumin  suppresses  p38 MAPK activation,  reduces  IL-1β and  MMP-3,  and enhances IL-10 expression in the mucosa of children and adults with inflammatory bowel disease. Epstein J, Docena G, MacDonald T, Sanderson I.  Br J Nutr 2009 Nov 2:1-9.